EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of KRAS, BRAF, PIK3CA gene mutations and mismatch repair deficiency in colorectal carcinoma patients: impact on clinicopathological features

Rabab A. Moussa, Zeinab F. Abdallah, Marwa Aboalsoud, Nisreen D. Toni

Egyptian Journal of Pathology · 2026-01 · 46 (1) · 1-15

DOI: 10.4103/egjp.egjp_20_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Pathology, online erschienen am 21.07.2026. Verfasst von Rabab A. Moussa und 3 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the world, colorectal cancer (CRC) is thought to be the primary cause of cancer death. The molecular etiology of sporadic CRC has identified many carcinogenic pathways. Patients and methods Fifty CRC patients were enrolled in this retrospective study. The mutational status of KRAS, BRAF, and PIK3CA was examined using the high-resolution melting (HRM) assay. Immunohistochemistry (IHC) was used to detect loss of the mismatch repair (MMR) proteins. Association with clinicopathologic characteristics were analyzed.

Results

In this study, the deletion rate of the MMR protein was 8/50 (16%). KRAS gene mutation was detected in 14/50 (28%) of studied cases. Mutation rate of BRAF was 6% (3/50), while mutation rate of PIK3CA was 20% (10/50). Eight percent of studied cases showed concomitant mutations. Significant association was detected between mutated KRAS and younger age ( P =0.007) and right colon location ( P =0.000). BRAF mutation significantly associated with right colon location ( P =0.015), tumor type ( P =0.017). No significant association was detected between PIK3CA gene mutation and various clinicopathological parameters ( P >0.05). dMMR cases associated with lower patient age ( P =0.021), right colon location ( P =0.021) and higher TILs ( P =0.016). The mutation rate of KRAS was higher in pMMR cases. Patients with multiple mutations had higher grade, mucoid adenocarcinoma type and exhibit right colon location. Conclusion dMMR protein is associated with a low rate of KRAS gene mutation and frequent BRAF and PIK3CA gene mutations. The prognostic significance of gene mutations in CRC patients should be evaluated while taking into account the concurrent mutation statuses of KRAS, BRAF, and PIK3CA.

Zitieren

APA

Moussa, R. A., Abdallah, Z. F., Aboalsoud, M., & Toni, N. D. (2026). Evaluation of KRAS, BRAF, PIK3CA gene mutations and mismatch repair deficiency in colorectal carcinoma patients: impact on clinicopathological features. Egyptian Journal of Pathology, 46(1), 1-15. https://doi.org/10.4103/egjp.egjp_20_25

Vancouver

Moussa RA, Abdallah ZF, Aboalsoud M, Toni ND. Evaluation of KRAS, BRAF, PIK3CA gene mutations and mismatch repair deficiency in colorectal carcinoma patients: impact on clinicopathological features. Egyptian Journal of Pathology. 2026;46(1):1-15. doi:10.4103/egjp.egjp_20_25

BibTeX
@article{Moussa2026,
  author = {Moussa, Rabab A. and Abdallah, Zeinab F. and Aboalsoud, Marwa and Toni, Nisreen D.},
  title = {Evaluation of KRAS, BRAF, PIK3CA gene mutations and mismatch repair deficiency in colorectal carcinoma patients: impact on clinicopathological features},
  journal = {Egyptian Journal of Pathology},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {1--15},
  doi = {10.4103/egjp.egjp_20_25}
}
Kostenlos starten →